Kolmar Korea Co., Ltd. (161890) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kolmar Korea Co., Ltd. (161890:KRX), powered by AI.

Current Price
₩88,400
P/E Ratio
16.7
Market Cap
2.1T
Sector
Consumer Defensive
What is the Kolmar Korea Co., Ltd. stock price forecast?

Kolmar Korea Co., Ltd. is currently trading at ₩88,400. View real-time AI analysis on Alpha Lenz.

What is Kolmar Korea Co., Ltd. insider trading activity?

View the latest insider trading data for Kolmar Korea Co., Ltd. on Alpha Lenz.

What is Kolmar Korea Co., Ltd.'s P/E ratio?

Kolmar Korea Co., Ltd.'s P/E ratio is 16.7.

Kolmar Korea Co., Ltd.

KRX · 161890
₩88,400+2,700(+3.15%)Market closedKRX regular session 09:00–15:30 KST
Ask about Kolmar Korea Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Kolmar Korea Co., Ltd. trades at a P/E of 16.7 (fair value) with solid ROE of 14.7%. 3Y revenue CAGR of 13.4% highlights clear growth momentum.

Ask for details

Company Overview

Kolmar Korea Co., Ltd. is a renowned entity in the cosmetics and pharmaceuticals manufacturing sector. Originally established in 1990, this South Korean company specializes in the contract manufacturing of comprehensive skincare, personal care products, and a portfolio of over-the-counter pharmaceuticals. Kolmar Korea primarily serves as an original development manufacturer (ODM) and original equipment manufacturer (OEM), partnering with various global brands to produce innovative and customized products. As a key player in the beauty and healthcare industries, the firm drives technological advancements in formulation and product design, catering to the dynamic demands of consumers worldwide. Its operations reflect a blend of tradition and innovation, aiming to deliver quality and effectiveness. The company's impact extends beyond its own products, significantly influencing industry standards and trends, and underlining its importance in the global supply chains of cosmetics and pharmaceuticals. Kolmar Korea Co., Ltd. continues to uphold its reputation by maintaining stringent quality control measures and investing in research and development to sustain its competitive edge in the market.

CEO최현규
SectorConsumer Defensive
IndustryHousehold & Personal Products
Employees1,152

Company Statistics

FY 2025

Profile

₩2,086,688,806,800Market Cap
₩2,722,419,169,320Revenue
23.61MShares Out
1,152Employees

Margins

29.07%Gross
12.95%EBITDA
8.81%Operating
7.78%Pre-Tax
6.18%Net

Valuation

16.68P/E
2.29P/B
0.77EV/Sales
10.92EV/EBITDA
18.68P/FCF

Growth (CAGR)

13.42%Rev 3Yr
15.54%Rev 5Yr
48.38%Op Inc 3Yr
14.54%Op Inc 5Yr
N/ANet Inc 3Yr
0.94%Net Inc 5Yr

Returns

5.11%ROA
14.69%ROE
7.61%ROIC

Financial Health

₩225,316,644,280Cash & Cash Equivalents
₩1,565,102,453,640Net Debt
107.38%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Kolmar Korea Co., Ltd. (ticker: 161890) is a company listed on KRX in the Consumer Defensive sector (Household & Personal Products). It has approximately 1,152 employees. Market cap is $2.1T.

The current price is ₩88,400 with a P/E ratio of 16.68x and P/B of 2.29x.

ROE is 14.69% and operating margin is 8.81%. Annual revenue is $2.7T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Kolmar Korea Co., Ltd. (161890) Stock Forecast 2026 ₩88,400 — Price, Financials & Analyst Targets | Alpha Lenz